Solta Medical, an aesthetic medical device maker being spun out of Bausch Health, filed on Tuesday with the SEC for an initial public offering.
Solta Medical describes itself as a leading global aesthetic medical device company. Its brands include Thermage, Clear + Brilliant, Fraxel, and VASER, which have a combined installed base of more than 13,800 systems, and a presence in approximately 50 countries as of December 31, 2020.
The Vaughan, Canada-based company was founded in 1995 and booked $306 million in sales for the 12 months ended September 30, 2021. It plans to list on the Nasdaq under the symbol SLTA. Solta Medical filed confidentially on September 3, 2021. Goldman Sachs, Morgan Stanley, Citi, Guggenheim Securities, Barclays, and Evercore ISI are the joint bookrunners on the deal. No pricing terms were disclosed.
